JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,021,326 | +6.5% | 6,351,322 | +25.5% | 0.01% | +20.0% |
| Q2 2023 | $60,095,389 | -51.7% | 5,062,796 | -50.8% | 0.01% | -16.7% |
| Q1 2023 | $124,403,584 | +68.5% | 10,281,288 | +83.4% | 0.01% | -14.3% |
| Q4 2022 | $73,829,176 | -12.7% | 5,605,860 | -10.3% | 0.01% | -22.2% |
| Q3 2022 | $84,589,000 | +18.9% | 6,247,392 | +7.2% | 0.01% | +28.6% |
| Q2 2022 | $71,132,000 | -12.6% | 5,825,704 | +2.6% | 0.01% | 0.0% |
| Q1 2022 | $81,407,000 | -17.3% | 5,676,926 | +13.7% | 0.01% | 0.0% |
| Q4 2021 | $98,480,000 | +25.9% | 4,991,402 | +38.1% | 0.01% | +16.7% |
| Q3 2021 | $78,202,000 | +70.0% | 3,615,431 | +96.1% | 0.01% | +50.0% |
| Q2 2021 | $45,997,000 | – | 1,843,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |